These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168 [TBL] [Abstract][Full Text] [Related]
4. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. Karakousis PC; Williams EP; Bishai WR J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern. Aggarwal P; Singal A; Bhattacharya SN; Mishra K Int J Dermatol; 2008 Jul; 47(7):681-7. PubMed ID: 18613873 [TBL] [Abstract][Full Text] [Related]
6. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages. Sood R; Rao M; Singhal S; Rattan A Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988 [TBL] [Abstract][Full Text] [Related]
7. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164 [TBL] [Abstract][Full Text] [Related]
8. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043 [TBL] [Abstract][Full Text] [Related]
9. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis. Hu Y; Coates AR; Mitchison DA Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713 [TBL] [Abstract][Full Text] [Related]
10. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569 [TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Khan A; Sarkar S; Sarkar D Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548 [TBL] [Abstract][Full Text] [Related]
12. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay. Marcel N; Nahta A; Balganesh M Chemotherapy; 2008; 54(5):404-11. PubMed ID: 18772589 [TBL] [Abstract][Full Text] [Related]
14. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970 [TBL] [Abstract][Full Text] [Related]
15. [Resistance rates to antituberculous drugs in Sivas province]. Gönlügür U; Bakici MZ; Gönlügür TE; Hasbek M Mikrobiyol Bul; 2007 Jul; 41(3):459-63. PubMed ID: 17933259 [TBL] [Abstract][Full Text] [Related]
16. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. Evans J; Stead MC; Nicol MP; Segal H J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875 [TBL] [Abstract][Full Text] [Related]
17. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. Wade MM; Zhang Y J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824 [TBL] [Abstract][Full Text] [Related]
18. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients. Abbadi S; El Hadidy G; Gomaa N; Cooksey R Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283 [TBL] [Abstract][Full Text] [Related]
19. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey]. Ozkütük N; Ecemiş T; Sürücüoğlu S Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079 [TBL] [Abstract][Full Text] [Related]
20. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. Shenai S; Rodrigues C; Mehta A Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]